Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CONFIDENCE: A PROSPECTIVE OBSERVATIONAL STUDY WITH ACUTE TREATMENT OF RIMEGEPANT ODT ON CONSISTENCY, SATISFACTION AND TOLERABILITY OF TREATMENT IN THE REAL WORLD

NCT06467370 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06467370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06467370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CONFIDENCE: A PROSPECTIVE OBSERVATIONAL STUDY WITH ACUTE TREATMENT OF RIMEGEPANT ODT ON CONSISTENCY, SATISFACTION AND TOLERABILITY OF TREATMENT IN THE REAL WORLD
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 2, 2024
Completion date
March 11, 2025
Enrollment
467 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine